Stryker's (SYK) Modular Hip Recall Could Impact Wright Medical (WMGI) - Analyst
Tweet Send to a FriendGet Alerts WMGI Hot Sheet
Price: $24.62 +0.12%
Rating Summary:
8 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 24
Rating Summary:
8 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 24
Trade WMGI Now!
Wright Medical (Nasdaq: WMGI) shares are hitting the skids today, falling to multi-month lows following the recall of Stryker's (NYSE: SYK) Rejuvenate and ABG II Modular-Neck Hip Implant Stems due to potential corrosion.
Though the recall was made a few days ago, Jefferies issued comments today highlighting the impact on Wright Medical.
The Stryker recall is likely to spark concerns over Wright Medical's Profemur hips. The analyst noted that Stryker's implants used a softer metal and it wasn't clear whether the stiffer titanium alloy used by Wright Medical would lessen the risk of corrosion.
However, Jefferies said it sees risk that all modular hip implants are likely to be affected following the recall.
The Profemur line accounts for most of Wright Medical's hip replacement sales.
Shares are down over 5 percent on the session Wendesday.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Though the recall was made a few days ago, Jefferies issued comments today highlighting the impact on Wright Medical.
The Stryker recall is likely to spark concerns over Wright Medical's Profemur hips. The analyst noted that Stryker's implants used a softer metal and it wasn't clear whether the stiffer titanium alloy used by Wright Medical would lessen the risk of corrosion.
However, Jefferies said it sees risk that all modular hip implants are likely to be affected following the recall.
The Profemur line accounts for most of Wright Medical's hip replacement sales.
Shares are down over 5 percent on the session Wendesday.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
